270 related articles for article (PubMed ID: 28569076)
1. Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.
Campos-Náñez E; Fortwaengler K; Breton MD
J Diabetes Sci Technol; 2017 Nov; 11(6):1187-1195. PubMed ID: 28569076
[TBL] [Abstract][Full Text] [Related]
2. Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.
Campos-Náñez E; Breton MD
J Diabetes Sci Technol; 2017 Nov; 11(6):1196-1206. PubMed ID: 28560900
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
4. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
[TBL] [Abstract][Full Text] [Related]
5. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
6. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
7. Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
Schnell O; Erbach M
J Diabetes Sci Technol; 2014 May; 8(3):479-82. PubMed ID: 24876609
[TBL] [Abstract][Full Text] [Related]
8. Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
Biagi L; Hirata Bertachi A; Conget I; Quirós C; Giménez M; Ampudia-Blasco FJ; Rossetti P; Bondia J; Vehí J
J Diabetes Sci Technol; 2017 Nov; 11(6):1089-1095. PubMed ID: 28633537
[TBL] [Abstract][Full Text] [Related]
9. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
[No Abstract] [Full Text] [Related]
10. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
11. A 5-Step Approach Protocol Using CareLink Therapy Software in Type 1 Diabetes Patients.
Petrovski G; Zivkovic M
J Diabetes Sci Technol; 2017 Nov; 11(6):1277. PubMed ID: 28879783
[No Abstract] [Full Text] [Related]
12. The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trial.
Hermanns N; Schumann B; Kulzer B; Haak T
J Diabetes Sci Technol; 2014 May; 8(3):516-22. PubMed ID: 24876615
[TBL] [Abstract][Full Text] [Related]
13. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
Klonoff DC; Kerr D
J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
[No Abstract] [Full Text] [Related]
14. The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.
Visentin R; Dalla Man C; Kovatchev B; Cobelli C
Diabetes Technol Ther; 2014 Jul; 16(7):428-34. PubMed ID: 24571584
[TBL] [Abstract][Full Text] [Related]
15. Clinical requirements for closed-loop control systems.
Clarke WL; Renard E
J Diabetes Sci Technol; 2012 Mar; 6(2):444-52. PubMed ID: 22538159
[TBL] [Abstract][Full Text] [Related]
16. Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter.
Schnell O; Klausmann G; Gutschek B; Garcia-Verdugo RM; Hummel M
J Diabetes Sci Technol; 2017 Nov; 11(6):1218-1225. PubMed ID: 28443343
[TBL] [Abstract][Full Text] [Related]
17. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.
Kerr D; Hoogma RP; Buhr A; Petersen B; Storms FE;
J Diabetes Sci Technol; 2010 Nov; 4(6):1400-7. PubMed ID: 21129336
[TBL] [Abstract][Full Text] [Related]
18. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
20. Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.
Schiavon M; Dalla Man C; Cobelli C
Diabetes Technol Ther; 2018 Feb; 20(2):98-105. PubMed ID: 29355438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
